Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity

Journal of General Virology

Volumn 84, Issue 11, 2003, Pages 3121-3129

  Römer Oberdörfer, Angela ^a   Werner, Ortrud ^a   Veits, Jutta ^a   Mebatsion, Teshome ^b   Mettenleiter, Thomas C ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HN PROTEIN; PROTEINASE; SIALIC ACID; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUSION; CONTROLLED STUDY; EMBRYO; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRULENCE; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; HN PROTEIN; MOLECULAR SEQUENCE DATA; NEWCASTLE DISEASE VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL FUSION PROTEINS;

ANIMALIA; DNA VIRUSES; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; RNA VIRUSES;

EID: 0242288634     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19416-0     Document Type: Article

References (37)

1. Alexander, D. J. (1997). Newcastle disease and other avian Paramyxoviridae infections. In Diseases of Poultry, 10th edn, pp. 541-569. Edited by B. W. Calnek. Ames, IA: Iowa State University Press.
2. Alexander, D. J. (1998). Newcastle disease and other avian paramyxoviruses. In A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 156-163. Edited by H. G. Purchase & L. H. Arp. Kennett Square: American Association of Avian Pathologists.
3. Buchholz, U. J., Finke, S. & Conzelmann, K. K. (1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73, 251-259.
4. CEC (1992). Council Directive 92/66/EEC, introducing community measures for the control of Newcastle disease, L 260, pp. 1-20. Official Journal of the European Community.
5. de Leeuw, O. & Peeters, B. (1999). Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 80, 131-136.
6. de Leeuw, O. S., Hartog, L., Koch, G. & Peeters, B. P. (2003). Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain. J Gen Virol 84, 475-484.
7. Garten, W., Berk, W., Nagai, Y., Rott, R. & Klenk, H. D. (1980). Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity. J Gen Virol 50, 135-147.
8. Glickman, R. L., Syddall, R. J., Iorio, R. M., Sheehan, J. P. & Bratt, M. A. (1988). Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol 62, 354-356.
9. Gorman, J. J., Nestorowicz, A., Mitchell, S. J., Corino, G. L. & Selleck, P. W. (1988). Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. J Biol Chem 263, 12522-12531.
10. Gorman, J. J., Hodder, A. N., Selleck, P. W. & Hansson, E. (1992). Antipeptide antibodies for analysis of pathotype-specific variations in cleavage activation of the membrane glycoprotein precursors of Newcastle disease virus isolates in cultured cells. J Virol Methods 37, 55-70.
11. Gotoh, B., Ogasawara, T., Toyoda, T., Inocencio, N. M., Hamaguchi, M. & Nagai, Y. (1990). An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J 9, 4189-4195.
12. Gotoh, B., Ohnishi, Y., Inocencio, N. M., Esaki, E., Nakayama, K., Barr, P. J., Thomas, G. & Nagai, Y. (1992). Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol 66, 6391-6397.
13. Kido, H., Yokogoshi, Y., Sakai, K., Tashiro, M., Kishino, Y., Fukutomi, A. & Katunuma, N. (1992). Isolation and characterization of novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267, 13573-13579.
14. Kolakofsky, D., Pelet, T., Garcin, D., Hausmann, S., Curran, J. & Roux, L. (1998). Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72, 891-899.
15. Krishnamurthy, S. & Samal, S. K. (1998). Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J Gen Virol 79, 2419-2424.
16. Krishnamurthy, S., Huang, Z. & Samal, S. K. (2000). Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278, 168-182.
17. Lamb, R. A. & Kolakofsky, D. (2001). Paramyxoviridae: the viruses and their replication. In Fields Virology, pp. 1305-1340. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
18. Mayo, M. A. (2002a). Virus taxonomy - Houston 2002. Arch Virol 147, 1071-1076.
19. Mayo, M. A. (2002b). A summary of taxonomic changes recently approved by ICTV. Arch Virol 147, 1655-1663.
20. Mebatsion, T., Verstegen, S., De Vaan, L. T., Römer-Oberdörfer, A. & Schrier, C. C. (2001). A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol 75, 420-428.
21. Morrison, T. & Portner, A. (1991). Structure, function, and intracellular processing of the glycoproteins of Paramyxoviridae. In Paramyxoviruses, pp. 347-382. Edited by D. W. Kingsbury. New York: Plenum.
22. Nagai, Y. (1993). Protease-dependent virus tropism and pathogenicity. Trends Microbiol 1, 81-87; erratum 1, 1.
23. Nagai, Y. & Klenk, H. D. (1977). Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 77, 125-134.
24. Nagai, Y., Klenk, H. D. & Rott, R. (1976). Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72, 494-508.
25. Nagai, Y., Shimokata, K., Yoshida, T., Hamaguchi, M., Iinuma, M., Maeno, K., Matsumoto, T., Klenk, H. D. & Rott, R. (1979). The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins. J Gen Virol 45, 263-272.
26. Nagai, Y., Hamaguchi, M. & Toyoda, T. (1989). Molecular biology of Newcastle disease virus. Prog Vet Microbiol Immunol 5, 16-64.
27. Peeters, B. P., de Leeuw, O. S., Koch, G. & Gielkens, A. L. (1999). Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73, 5001-5009.
28. Peeters, B. P., Gruijthuijsen, Y. K., de Leeuw, O. S. & Gielkens, A. L. (2000). Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145, 1829-1845.
29. Römer-Oberdörfer, A., Mundt, E., Mebatsion, T., Buchholz, U. J. & Mettenleiter, T. C. (1999). Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80, 2987-2995.
30. Sakaguchi, T., Toyoda, T., Gotoh, B., Inocencio, N. M., Kuma, K., Miyata, T. & Nagai, Y. (1989). Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169, 260-272.
31. Sato, H., Hattori, S., Ishida, N., Imamura, Y. & Kawakita, M. (1987). Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains. Virus Res 8, 217-232.
32. Scheid, A. & Choppin, P. W. (1973). Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol 11, 263-271.
33. Schuy, W., Garten, W., Linder, D. & Klenk, H. D. (1984). The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Res 1, 415-426.
34. Steward, M., Vipond, I. B., Millar, N. S. & Emmerson, P. T. (1993). RNA editing in Newcastle disease virus. J Gen Virol 74, 2539-2547.
35. Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N. M., Gotoh, B., Hamaguchi, M. & Nagai, Y. (1987). Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158, 242-247.
36. Toyoda, T., Sakaguchi, T., Hirota, H., Gotoh, B., Kuma, K., Miyata, T. & Nagai, Y. (1989). Newcastle disease evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology 169, 273-282.
37. Werner, O., Römer-Oberdörfer, A., Köllner, B., Manvell, R. J. & Alexander, D. J. (1999). Characterization of avian paramyxovirus type 1 strains isolated in Germany during 1992 to 1996. Avian Pathol 28, 79-88.